145 related articles for article (PubMed ID: 30143500)
1. CYP3A4*1B Polymorphism and Cancer Risk: A Meta-Analysis Based on 55 Case-control Studies.
Zheng Y; Xu Y; Zhou BY; Sun L; Yu PB; Zhang L; Xu J; Wang JJ
Ann Clin Lab Sci; 2018 Jul; 48(4):538-545. PubMed ID: 30143500
[TBL] [Abstract][Full Text] [Related]
2. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
3. CYP3A4*1B polymorphism and cancer risk: a HuGE review and meta-analysis.
Zhou LP; Yao F; Luan H; Wang YL; Dong XH; Zhou WW; Wang QH
Tumour Biol; 2013 Apr; 34(2):649-60. PubMed ID: 23179402
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of vascular endothelial growth factor -1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies.
Hong TT; Zhang RX; Wu XH; Hua D
Mol Biol Rep; 2012 May; 39(5):5283-9. PubMed ID: 22167330
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
[TBL] [Abstract][Full Text] [Related]
6. Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression.
He XF; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Wei W
Tumour Biol; 2014 Oct; 35(10):9859-77. PubMed ID: 24989928
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between leptin G-2548A polymorphisms and obesity risk: Evidence based on a meta-analysis.
Yan J; Wang X; Tao H; Yang W; Luo M; Lin F
Obes Res Clin Pract; 2015; 9(4):389-97. PubMed ID: 25733497
[TBL] [Abstract][Full Text] [Related]
8. Association of TNF-α-308 and -238 polymorphisms with risk of cervical cancer: a meta-analysis.
Pan F; Tian J; Ji CS; He YF; Han XH; Wang Y; Du JP; Jiang FS; Zhang Y; Pan YY; Hu B
Asian Pac J Cancer Prev; 2012; 13(11):5777-83. PubMed ID: 23317256
[TBL] [Abstract][Full Text] [Related]
9. Association of the
Zhang W; Deng XW; Tang RJ; Gu JR; Wang H
Genet Test Mol Biomarkers; 2020 Oct; 24(10):685-688. PubMed ID: 32991209
[No Abstract] [Full Text] [Related]
10. Assessment of the association between ZBTB20 rs9841504 polymorphism and gastric and esophageal cancer susceptibility: a meta-analysis.
Shi J; Li W; Ding X
Int J Biol Markers; 2017 Mar; 32(1):e96-e101. PubMed ID: 27646774
[TBL] [Abstract][Full Text] [Related]
11. The GSTP1 A1578G polymorphism and the risk of childhood acute lymphoblastic leukemia: results from an updated meta-analysis.
Huang GZ; Shan W; Zeng L; Huang LG
Genet Mol Res; 2013 Jul; 12(3):2481-91. PubMed ID: 23979883
[TBL] [Abstract][Full Text] [Related]
12. The association between common genetic variant of microRNA-146a and cancer susceptibility.
Qiu LX; He J; Wang MY; Zhang RX; Shi TY; Zhu ML; Mao C; Sun S; Lv FF; Zheng CL; Zhu XD
Cytokine; 2011 Dec; 56(3):695-8. PubMed ID: 21978540
[TBL] [Abstract][Full Text] [Related]
13. SCN1A rs3812718 polymorphism and susceptibility to epilepsy with febrile seizures: a meta-analysis.
Tang L; Lu X; Tao Y; Zheng J; Zhao P; Li K; Li L
Gene; 2014 Jan; 533(1):26-31. PubMed ID: 24076350
[TBL] [Abstract][Full Text] [Related]
14. Genetic G2548A polymorphism of leptin gene and risk of cancer: a meta-analysis of 6860 cases and 7956 controls.
Yang Y; Liu P; Guo F; Liu R; Yang Y; Huang C; Shu H; Gong J; Cai M
J BUON; 2014; 19(4):1096-104. PubMed ID: 25536622
[TBL] [Abstract][Full Text] [Related]
15. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract][Full Text] [Related]
16. The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.
Tang Z; Nie ZL; Pan Y; Zhang L; Gao L; Zhang Q; Qu L; He B; Song G; Zhang Y; Shukui Wang
Mutagenesis; 2011 Nov; 26(6):729-34. PubMed ID: 21734230
[TBL] [Abstract][Full Text] [Related]
17. Genetic Polymorphism of DNA Methyltransferase 3A rs1550117 A>G and Risk of Cancer: A Meta-analysis.
Zhang W; Xu Y; Ma G; Qi W; Gu H; Jiang P
J Invest Surg; 2015; 28(6):346-53. PubMed ID: 26203494
[TBL] [Abstract][Full Text] [Related]
18. XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
Liu J; Zhang Z; Cao XL; Lei DP; Wang ZQ; Jin T; Pan XL
Mol Biol Rep; 2012 Jun; 39(6):6791-9. PubMed ID: 22314912
[TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-analysis of 17 case-control studies.
Wang Y; Yang B; Ren X
Gene; 2012 Nov; 509(2):267-72. PubMed ID: 22922391
[TBL] [Abstract][Full Text] [Related]
20. Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis.
Tan SC; Lim PY; Fang J; Mokhtar MFM; Hanif EAM; Jamal R
Sci Rep; 2020 Feb; 10(1):3508. PubMed ID: 32103099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
